Accelevir Diagnostics

United States of America (USA)

1 December 2018 - 30 November 2019

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Accelevir Diagnostics published between 1 December 2018 - 30 November 2019 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
2 0.06

Outputs by subject (Share)

Subject Count Share
Life Sciences 2 0.06

1 December 2018 - 30 November 2019

International vs. domestic collaboration by Share

  • 97.38% Domestic
  • 2.62% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (11 total)

  • Accelevir Diagnostics, United States of America (USA)
  • Domestic institution
  1. Johns Hopkins University (JHU), United States of America (USA) (1.43)
    0.06
    1.37
  2. University of Pennsylvania (Penn), United States of America (USA) (0.15)
    0.04
    0.12
  3. Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA) (0.10)
    0.02
    0.08
  4. Harvard University, United States of America (USA) (0.10)
    0.02
    0.08
  5. Oregon Health and Science University (OHSU), United States of America (USA) (0.10)
    0.02
    0.08
  6. University of Washington (UW), United States of America (USA) (0.10)
    0.02
    0.08
  7. University of California, San Francisco (UCSF), United States of America (USA) (0.08)
    0.04
    0.04
  8. Leidos Holdings, Inc., United States of America (USA) (0.06)
    0.02
    0.04
  9. National Institutes of Health (NIH), United States of America (USA) (0.06)
    0.02
    0.04
  10. The University of Texas at Austin (UT Austin), United States of America (USA) (0.06)
    0.04
    0.02

Top 10 international collaborators by Share (1 total)

  • Accelevir Diagnostics, United States of America (USA)
  • Foreign institution
  1. CHU Fann (CHNUF), Senegal (0.06)
    0.02
    0.04

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Accelevir Diagnostics
Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER